Federal grants to Analytical Diagnostic Solutions Inc
Analytical Diagnostic Solutions Inc in Mount Laurel, New Jersey received $6.0 million in federal grants from fiscal 2021 to 2025, across 8 awards. Its largest program was Allergy and Infectious Diseases Research, with $3.5 million. In fiscal 2025 it was awarded $1.2 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$6.0 million
- Awards8
- Awarded in FY 2025$1.2 million
- Largest award$2.9 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $2.0 million |
| FY 2022 | 1 | $920,583 |
| FY 2023 | 4 | $1.9 million |
| FY 2024 | 0 | $0 |
| FY 2025 | 3 | $1.2 million |
Programs that fund Analytical Diagnostic Solutions Inc
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 3 | $3.5 million |
| Biomedical Research and Research Training | 1 | $1.0 million |
| Child Health and Human Development Extramural Research | 2 | $901,925 |
| National Center for Advancing Translational Sciences | 1 | $305,352 |
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 1 | $291,361 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 8 | $6.0 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Prequine platform. A novel point of care device for the diagnosis andmonitoring of GLUCOSE-6-PHOSPHATE dehydrogenase (G6PD) - abstract malaria caused by plasmodium species threatens more than 2.5 billion people globally and sickens tens of millions annually. Radical cure for p. Vivax and p. Ovale re | Allergy and Infectious Diseases Research | August 16, 2021 | $2.9 million |
| A point-of-care device for phenylalanine determination | Biomedical Research and Research Training | August 3, 2021 | $1.0 million |
| A point of care-device for the determination of creatinine phosphokinase (CPK), thecpk now - abstract in vitro diagnostic solutions (IVDS) proposes to develop a point-of-care test (POCT) to rapidly determine blood creatine phosphokinase (CPK) activity for the improved management of a range of condit | Child Health and Human Development Extramural Research | September 22, 2025 | $606,002 |
| A point-of-care device for the determination of homocysteine (HCY), the hcy now - abstract this application pertains to the national center for advancing translational sciences sbir/sttr omnibus solicitation (preferred). In vitro diagnostic solutions (IVDS) aims to develop a quantitative, home monit | National Center for Advancing Translational Sciences | June 27, 2025 | $305,352 |
| A point of care-device for the determination of creatinine phosphokinase (CPK), thecpk now - abstract in vitro diagnostic solutions (IVDS) proposes to develop a point-of-care test (POCT) to rapidly determine blood creatine phosphokinase (CPK) activity for the improved management of a range of condit | Allergy and Infectious Diseases Research | September 22, 2025 | $300,000 |
| ADA2 diagnostic platform: point-of-care test for determination of patient enzyme levels for diagnosis of the rare disease DEAMINASE2 deficiency (DADA2) - abstract this application is in regard to the national center for advancing translational sciences sbir/sttr omnibus solicitation (research priori | Allergy and Infectious Diseases Research | August 18, 2023 | $300,000 |
| A point of care-device for the determination of creatinine phosphokinase (CPK), the cpk now - abstract this application is in regard to the national center for advancing translational sciences sbir/sttr omnibus solicitation. In vitro diagnostic solutions, LLC (IVDS) proposes to develop a point-of-ca | Child Health and Human Development Extramural Research | September 20, 2023 | $295,923 |
| Pku now-connect: an intelligent digital ecosystem to improve health outcomes in phenylketonuria - abstract phenylketonuria (PKU) is an inherited genetic disorder that results in an inability to metabolize the essential amino acid phenylalanine (PHE). Consequences of uncontrolled blood phe include in | Extramural Research Programs in the Neurosciences and Neurological Disorders | September 19, 2023 | $291,361 |
Questions people ask
How much federal grant money does Analytical Diagnostic Solutions Inc get?
$6.0 million in 8 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Analytical Diagnostic Solutions Inc the most?
The Department of Health and Human Services, with $6.0 million in 8 awards.
What is Analytical Diagnostic Solutions Inc's largest federal grant?
$2.9 million under Allergy and Infectious Diseases Research, with its first action in the period on August 16, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Analytical Diagnostic Solutions Inc?
Its largest are Allergy and Infectious Diseases Research, Biomedical Research and Research Training and Child Health and Human Development Extramural Research.
Other grant recipients in Mount Laurel
Largest federal grant recipients in New Jersey · Federal grants in New Jersey